Annals ofOncology

Volume: 3 - Number: 23 - December 15, 2003

Outstanding

HER-2/neu Expression and Gene Amplification in Gastrinomas: Correlations with Tumor Biology, Growth, and Aggressiveness

Haplotypes of Two Variants in p16 (CDKN2/MTS-1/INK4a) Exon 3 and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case-Control Study

Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-Phase Myeloid Leukemia after Failure of Interferon-: Follow-Up Results

Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p21CIP1 and Inhibition of Expression of Cyclin D2

Advances

Genomic Copy Number Analysis of Non-small Cell Lung Cancer Using Array Comparative Genomic Hybridization: Implications of the Phosphatidylinositol 3-Kinase Pathway

Inactivation of LKB1/STK11 Is a Common Event in Adenocarcinomas of the Lung

Advances in Clinical Assays

Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells

Biochemical and Biophysics

Hyaluronan-CD44s Signaling Regulates Matrix Metalloproteinase-2 Secretion in a Human Lung Carcinoma Cell Line QG91

Briefs Communications

HER-2/neu Gene Amplification in Ductal Carcinoma In Situ of the Breast

Carcinogenesis

Inhibition of Carcinogen-activating Enzymes by 16-Fluoro-5-androsten-17-one

Endocrinology

HER-2/neu Expression and Gene Amplification in Gastrinomas: Correlations with Tumor Biology, Growth, and Aggressiveness

Epidemiology and Prevention

Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p21CIP1 and Inhibition of Expression of Cyclin D2

Experimental Therapeutics

Heterogeneity in Interleukin-13 Receptor Expression and Subunit Structure in Squamous Cell Carcinoma of Head and Neck: Differential Sensitivity to Chimeric Fusion Proteins Comprised of Interleukin-13 and a Mutated Form of Pseudomonas Exotoxin

Hypoestoxide, a Natural Nonmutagenic Diterpenoid with Antiangiogenic and Antitumor Activity: Possible Mechanisms of Action

Inactivation of the Antiapoptotic Phosphatidylinositol 3-Kinase-Akt Pathway by the Combined Treatment of Taxol and Mitogen-activated Protein Kinase Kinase Inhibition

Inhibition of Nuclear Factor B Activation in PC3 Cells by Genistein Is Mediated via Akt

Immunology

Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel

Investigational Article

Haplotypes of Two Variants in p16 (CDKN2/MTS-1/INK4a) Exon 3 and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case-Control Study

Incorporating Genetic Susceptibility Feedback into a Smoking Cessation Program for African-American Smokers with Low Income

Molecular and Genetic Biology

Hypermethylation of HIC-1 and 17p Allelic Loss in Medulloblastoma

Preclinical pharmacology and experimental therapeutics

Inhibition of Furin-mediated Processing Results in Suppression of Astrocytoma Cell Growth and Invasiveness

Regulary Articles

Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-Phase Myeloid Leukemia after Failure of Interferon-: Follow-Up Results

Tumoral Biology

Herceptin-induced Inhibition of Phosphatidylinositol-3 Kinase and Akt Is Required for Antibody-mediated Effects on p27, Cyclin D1, and Antitumor Action